Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Calendar Review
JCCC Seminar Featuring Dr. Thomas Graeber
How Targeted Therapies Exploit Signaling (Src) and Metabolic (Glucose) Over-Dependencies in Cancer Homeostasis
Date: 4/18/2013
Time: 12:00 PM - 1:00 PM
Cost: Free
Location: 73-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095

JCCC SeminarDr. Thomas Graeber

Presented by:
Thomas Graeber, Ph.D.
Associate Professor, Department of Molecular and Medical Pharmacology
Member, JCCC Cancer Nanotechnology Program Area

Dr. Thomas Graeber's lab is working to understand cancer signaling from a systems viewpoint. They focus on developing genome- and proteome-wide detection assays, applying these assays to measuring and computationally modeling aberrant cancer signaling and translating their discoveries to clinical applications. In modeling cancer signaling, one of their goals is to identify minimal sets of informative components that best reflect the state of the cell and serve as molecular targets for diagnostics, imaging and patient tailored treatment.

Light lunch served.

Sponsored by the JCCC Cancer Nanotechnology Program Area.